Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Malignant Lymphoma

  Free Subscription


15.04.2024

1 AJR Am J Roentgenol
1 Am J Clin Pathol
2 Am J Hematol
1 Am J Surg Pathol
4 Blood
1 BMC Cancer
1 Br J Dermatol
4 Br J Haematol
2 J Am Acad Dermatol
2 Leuk Lymphoma
1 Leukemia
2 Proc Natl Acad Sci U S A


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AJR Am J Roentgenol

  1. MARCUS C
    Editorial Comment: FDG PET/CT Has Impact in CAR T-Cell Therapy Response Assessment and Outcome Prediction.
    AJR Am J Roentgenol. 2023 Dec 20. doi: 10.2214/AJR.23.30703.
    PubMed        


    Am J Clin Pathol

  2. DERNELL C, Astle J, Bogachkov A, Reimer S, et al
    Improving resource utilization: Axillary lymph node core biopsy triaging for lymphoma.
    Am J Clin Pathol. 2024 Apr 9:aqae032. doi: 10.1093.
    PubMed         Abstract available


    Am J Hematol

  3. CHOQUET S, Soussain C, Azar N, Morel V, et al
    CAR T-cell therapy induces a high rate of prolonged remission in relapsed primary CNS lymphoma: Real-life results of the LOC network.
    Am J Hematol. 2024 Apr 8. doi: 10.1002/ajh.27316.
    PubMed         Abstract available

  4. MOU E, Fernandez-Pol S, Li S, Rieger KE, et al
    Clinical characteristics, treatment patterns, and outcomes of cytotoxic cutaneous T-cell lymphomas.
    Am J Hematol. 2024;99:985-988.
    PubMed        


    Am J Surg Pathol

  5. COTTA CV, Bhavsar S, Robertson S, Cook JR, et al
    Patients with Classic Hodgkin Lymphoma and Follicular Lymphoma Compared to Single Malignancy Controls.
    Am J Surg Pathol. 2024 Apr 11. doi: 10.1097/PAS.0000000000002225.
    PubMed         Abstract available


    Blood

  6. MERLIO JP
    Staphylococcus aureus and Sezary syndrome.
    Blood. 2024;143:1436-1438.
    PubMed        

  7. WEI Q, Bueso-Ramos CE
    Thymoma with aberrant expression of CD20: a potential diagnostic pitfall of B-cell lymphoma.
    Blood. 2024;143:1551.
    PubMed        

  8. KROEZE E, Iaccarino I, Kleisman MM, Mondal M, et al
    Mutational and transcriptional landscape of pediatric B-cell precursor lymphoblastic lymphoma.
    Blood. 2024 Apr 8:blood.2024023938. doi: 10.1182/blood.2024023938.
    PubMed         Abstract available

  9. VADIVEL CK, Willerslev-Olsen A, Namini MRJ, Zeng Z, et al
    Staphylococcus aureus induces drug resistance in cancer T cells in Sezary syndrome.
    Blood. 2024;143:1496-1512.
    PubMed         Abstract available


    BMC Cancer

  10. SUN H, Shang J, Liu X, Ren S, et al
    Eukaryotic initiation factor 3a promotes the development of diffuse large B-cell lymphoma through regulating cell proliferation.
    BMC Cancer. 2024;24:432.
    PubMed         Abstract available


    Br J Dermatol

  11. BLANCHARD M, Morren MA, Busschots AM, Hauben E, et al
    Paediatric onset lymphomatoid papulosis: results of a multicentre retrospective cohort study, on behalf of the EORTC Cutaneous Lymphoma Tumours Group (CLTG).
    Br J Dermatol. 2024 Apr 10:ljae150. doi: 10.1093.
    PubMed         Abstract available


    Br J Haematol

  12. MOULIN C, Beaupain B, Suarez F, Bertrand Y, et al
    CXCR4 WHIM syndrome is a cancer predisposition condition for virus-induced malignancies.
    Br J Haematol. 2024;204:1383-1392.
    PubMed         Abstract available

  13. BOMMANNAN K, Arumugam JR, Radhakrishnan V, Sundersingh S, et al
    Relevance of CD20 antigen expression among paediatric patients with B-lineage acute lymphoblastic leukaemia.
    Br J Haematol. 2024;204:1367-1374.
    PubMed         Abstract available

  14. MARTYNCHYK A, Hawkes EA
    Learnings from phosphatidylinositol 3-kinase inhibitors in lymphoma-Moving to a model where less can be more.
    Br J Haematol. 2024 Apr 6. doi: 10.1111/bjh.19456.
    PubMed         Abstract available

  15. KUHNL A, Roddie C, Kirkwood AA, Chaganti S, et al
    Outcome and feasibility of radiotherapy bridging in large B-cell lymphoma patients receiving CD19 CAR T in the UK.
    Br J Haematol. 2024 Apr 9. doi: 10.1111/bjh.19453.
    PubMed         Abstract available


    J Am Acad Dermatol

  16. HASAN I, Parsons L, Duran S, Zinn Z, et al
    Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: a retrospective cohort study.
    J Am Acad Dermatol. 2024 Apr 6:S0190-9622(24)00566.
    PubMed         Abstract available

  17. POWERS CM, Piontkowski AJ, Orloff J, Pulsinelli J, et al
    Risk of lymphoma in patients with atopic dermatitis: A case-control study in the All of Us database.
    J Am Acad Dermatol. 2024 Apr 4:S0190-9622(24)00554.
    PubMed        


    Leuk Lymphoma

  18. SANCHO JM, Abrisqueta P, Kumar A, Cordoba R, et al
    Safety and efficacy of parsaclisib in combination with rituximab, bendamustine + rituximab, or ibrutinib in patients with previously treated B-cell lymphoma: analysis of a phase 1 dose-finding study (CITADEL?112).
    Leuk Lymphoma. 2024 Apr 10:1-11. doi: 10.1080/10428194.2024.2331626.
    PubMed         Abstract available

  19. SCHAFF L, Nayak L, Grommes C
    Bruton's tyrosine kinase (BTK) inhibitors for the treatment of primary central nervous system lymphoma (PCNSL): current progress and latest advances.
    Leuk Lymphoma. 2024 Apr 10:1-13. doi: 10.1080/10428194.2024.2333985.
    PubMed         Abstract available


    Leukemia

  20. DELROCCO NJ, Loh ML, Borowitz MJ, Gupta S, et al
    Enhanced Risk Stratification for Children and Young Adults with B-Cell Acute Lymphoblastic Leukemia: A Children's Oncology Group Report.
    Leukemia. 2024 Feb 15. doi: 10.1038/s41375-024-02166.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  21. MAROUI MA, Odongo GA, Mundo L, Manara F, et al
    Aflatoxin B1 and Epstein-Barr virus-induced CCL22 expression stimulates B cell infection.
    Proc Natl Acad Sci U S A. 2024;121:e2314426121.
    PubMed         Abstract available

  22. KRISTENSON L, Badami C, Ljungberg A, Islamagic E, et al
    Deletion of the TMEM30A gene enables leukemic cell evasion of NK cell cytotoxicity.
    Proc Natl Acad Sci U S A. 2024;121:e2316447121.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.